The Na+–H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells

Breast Cancer Research

Stephan J Reshkin¹  Valeria Casavola¹  Massimo Tommasino³  Lorenzo Guerra¹  Anna Bagorda¹  Antonia Bellizzi¹  Rosa Angela Cardone¹  Angelo Paradiso² 

[1] Department of General and Environmental Physiology, University of Bari, Bari, Italy;Laboratory of Clinical & Experimental Oncology, Oncology Institute of Bari, Bari, Italy;International Agency for Research on Cancer, World Health Organization, Unit of Infection and Cancer, Lyon, France

关键词: Rho GTPases;    invasion;    NHE1;    metastasis;    cytoskeleton;   

Others  :  1118719
DOI  :  10.1186/bcr922

 received in 2004-04-28, accepted in 2004-07-21,  发布年份 2004

【 摘 要 】

Introduction

An increasing body of evidence shows that the tumour microenvironment is essential in driving neoplastic progression. The low serum component of this microenvironment stimulates motility/invasion in human breast cancer cells via activation of the Na⁺–H⁺ exchanger (NHE) isoform 1, but the signal transduction systems that underlie this process are still poorly understood. We undertook the present study to elucidate the role and pattern of regulation by the Rho GTPases of this serum deprivation-dependent activation of both NHE1 and subsequent invasive characteristics, such as pseudopodia and invadiopodia protrusion, directed cell motility and penetration of normal tissues.

Methods

The present study was performed in a well characterized human mammary epithelial cell line representing late stage metastatic progression, MDA-MB-435. The activity of RhoA and Rac1 was modified using their dominant negative and constitutively active mutants and the activity of NHE1, cell motility/invasion, F-actin content and cell shape were measured.

Results

We show for the first time that serum deprivation induces NHE1-dependent morphological and cytoskeletal changes in metastatic cells via a reciprocal interaction of RhoA and Rac1, resulting in increased chemotaxis and invasion. Deprivation changed cell shape by reducing the amount of F-actin and inducing the formation of leading edge pseudopodia. Serum deprivation inhibited RhoA activity and stimulated Rac1 activity. Rac1 and RhoA were antagonistic regulators of both basal and stimulated tumour cell NHE1 activity. The regulation of NHE1 activity by RhoA and Rac1 in both conditions was mediated by an alteration in intracellular proton affinity of the exchanger. Interestingly, the role of each of these G-proteins was reversed during serum deprivation; basal NHE1 activity was regulated positively by RhoA and negatively by Rac1, whereas RhoA negatively and Rac1 positively directed the stimulation of NHE1 during serum deprivation. Importantly, the same pattern of RhoA and Rac1 regulation found for NHE1 activity was observed in both basal and serum deprivation dependent increases in motility, invasion and actin cytoskeletal organization.

Conclusion

Our findings suggest that the reported antagonistic roles of RhoA and Rac1 in cell motility/invasion and cytoskeletal organization may be due, in part, to their concerted action on NHE1 activity as a convergence point.

【 授权许可】

   
2004 Paradiso et al; BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Chambers AF: The metastatic process: basic research and clinical implications. Oncol Res 1999, 11:161-168.
• [2]Cuvier C, Jang A, Hill RP: Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L & B) secretion. Clin Exp Metastasis 1997, 15:9-25.
• [3]Park CP, Bissell MJ, Barcellos-Hoff MH: The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000, 6:324-329.
• [4]Williams AC, Collard TJ, Paraskeva C: An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene 1999, 18:3199-3204.
• [5]Boyer MJ, Tannock IF: Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions. Cancer Res 1992, 52:4441-4447.
• [6]Reshkin SJ, Bellizzi A, Albarani V, Guerra L, Tommasino M, Paradiso A, Casavola V: Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na/H exchange, motility and invasion induced by serum deprivation. J Biol Chem 2000, 275:5361-5369.
• [7]Lagana A, Vadnais J, Le PU, Nguyen TN, Laprade R, Nabi IR, Noel J: Regulation of the formation of tumor cell pseudopodia by the Na+/H+ exchanger NHE1. J Cell Sci 2000, 113:3649-3662.
• [8]Klein M, Seeger P, Schuricht B, Alper SL, Schwa A: Polarization of Na+/H+ and Cl-/HCO3- exchangers in migrating renal epithelial cells. J Gen Physiol 2000, 115:599-607.
• [9]Iwasaki T, Nakata A, Mukai M, Shinkai K, Yano H, Sabe H, Schaefer E, Tatsuta M, Tsujimura T, Terada N, et al.: Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration. Int J Cancer 2002, 97:330-335.
• [10]Hall A: Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
• [11]Welsh CF, Assoian RK: A growing role for Rho family GTPases as intermediaries in growth factor-and adhesion-dependent cell cycle progression. Biochem Biophys Acta 2000, 1471:M21-M29.
• [12]Boshans RL, Szanto S, van Aelst L, D'Souza-Schorey C: ADP-ribosylation factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA. Mol Cell Biol 2000, 20:3685-3694.
• [13]Yuan X, Jin M, Xu X, Song Y, Wu C, Poo M, Duan S: Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nature Cell Biol 2003, 5:38-45.
• [14]Leemhuis J, Boutillier S, Barth H, Feuerstein TJ, Brock C, Nürnberg B, Aktories K, Meyer DK: Rho GTPases and phosphoinositide 3-kinase organize formation of branched dendrites. J Biol Chem 2004, 279:585-596.
• [15]Nobes CD, Hall A: Rho GTPases control polarity, protrusion and adhesion during cell movement. J Cell Biol 1999, 144:1235-1244.
• [16]Noren NK, Liu BP, Burridge K, Kreft B: P120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 2000, 150:567-580.
• [17]Nimnual AS, Taylor LJ, Bar-Sagi D: Redox-dependent down-regulation of Rho by Rac. Nat Cell Biol 2003, 5:236-241.
• [18]Lozano E, Betson M, Bragg VMM: Tumor progression: small GTPases and loss of cell-cell adhesion. BioEssays 2003, 25:452-463.
• [19]Lin M, van Golen KL: Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat 2004, 84:49-60.
• [20]Frame MC, Brunton VG: Advances in Rho-dependent actin regulation and oncogenic transformation. Curr Opin Genet Dev 2002, 12:36-43.
• [21]Burridge K: Crosstalk between Rac and Rho. Science 1996, 283:2028-2029.
• [22]Horwitz AR, Parsons JT: Cell migration–movin' on. Science 1999, 286:1102-1103.
• [23]Ridley AJ: Rho family proteins: coordinating cell responses. Trends Cell Biol 2001, 11:471-477.
• [24]Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL: Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003, 302:1775-1779.
• [25]Denker SP, Huang DC, Orlowski J, Furthmayr H, Barber DL: Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H+ translocation. Mol Cell 2000, 6:1425-1436.
• [26]Denker SP, Barber DL: Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J Cell Biol 2002, 159:1087-1096.
• [27]Liotta LA, Kohn EC: The microenvironment of the tumour–host interface. Nature 2001, 411:375-379.
• [28]Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al.: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
• [29]Evers EE, van der Kammen RA, ten Klooster JP, Collard JG: Rho-like GTPases in tumor cell invasion. Methods Enzymol 2000, 325:403-415.
• [30]Korichneva I, Hammerling U: F-actin as a functional target for retro-retinoids: a potential role in anhydroretinol-triggered cell death. J Cell Sci 1999, 112:2521-2528.
• [31]Kurashima K, D'Sousa S, Szászi K, Ramjeesingh R, Orlowski J, Grinstein S: The apical Na+/H+ exchanger isoform NHE3 is regulated by the actin cytoskeleton. J Biol Chem 1999, 274:29843-29849.
• [32]Tominaga T, Ishizaki T, Narumiya S, Barber DL: p160ROCK mediates RhoA activation of Na-H exchange. EMBO J 1998, 17:4712-4722.
• [33]Wittchen ES, Haskins J, Stevenson BR: NZO-3 expression causes global changes to actin cytoskeleton in Madin–Darby canine kidney cells: linking a tight junction protein to Rho GTPases. Mol Biol Cell 2003, 14:1757-1768.
• [34]McHardy LM, Sinotte R, Troussard A, Sheldon C, Church J, Williams DE, Anderson RJ, Dedhar S, Roberge M, Roskelley CD: The tumor invasion inhibitor dihyromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Res 64:1468-1475.
• [35]Arthur WT, Petch LA, Burridge K: Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr Biol 2000, 10:719-722.
• [36]Noren NK, Niessen CM, Gumbiner BM, Burridge K: Cadherin engagement regulates Rho family GTPases. J Biol Chem 2001, 276:33305-33308.
• [37]Bowden ET, Coopman PJ, Mueller SC: Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol 2001, 63:613-627.
• [38]Hauck CR, Hsia DA, Ilic D, Schlaepfer DD: v-src SH3-enhanced interaction with focal adhesion kinase at β1 integrin-containing invadopodia promotes cell invasion. J Biol Chem 2002, 277:12487-12490.
• [39]Hancock JF, Moon RT: Cell regulation. Cellular aspects of signal transduction. Curr Opin Cell Biol 2000, 12:153-156.
• [40]Voltz JW, Weinman EJ, Shenolikar S: Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 2001, 20:6309-6314.
• [41]Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999, 5:221-225.
• [42]Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG: Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity, and epithelial-mesenchymal transition. J Cell Biol 2000, 149:775-782.
• [43]Sahai E, Ishizaki T, Narumiya S, Treisman R: Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol 1999, 9:136-145.
• [44]Yoshioka K, Nakamori S, Itoh K: Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999, 59:2004-2010.